Tag: <span>James Matarese</span>

North America Legal Chronicle. July 20, 2023

Evelo Biosciences’ $25.5 Million Private Placement

By Pietro Martinoia

Goodwin advised Flagship Pioneering on the investment. Evelo Biosciences, Inc. (Nasdaq:EVLO) announced a securities purchase agreement with investors in a private placement to sell 11,025,334 shares of...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. May 25, 2023

Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding

By Marco Zingaro

Advestra and Latham & Watkins advise Ironwood. Homburger AG serves as legal and tax advisor to VectivBio on the transaction. Goodwin advises Centerview Partners. VectivBio Holding...

This content is for Standard 1 Year members only.
Login Join Now

Europe Legal Chronicle. May 3, 2023

Mercy BioAnalytics’ $41 Million Series A Financing

By Martina Bellini

Goodwin advised Mercy BioAnalytics, Inc. on the deal. Mercy BioAnalytics, Inc. announced its $41 million Series A financing round. The financing was led by Novalis LifeSciences, with...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. April 5, 2023

Avadel Pharmaceuticals’ $75 Million Royalty Financing

By Martina Bellini

Goodwin Procter advised Avadel Pharmaceutics on the deal. Avadel announced its royalty agreement with RTW Investments, LP and certain of its affiliates for up to $75 million....

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. March 28, 2023

Moderna’s Collaboration with Generation Bio

By Martina Bellini

Goodwin advised Moderna, Inc. on the deal. Moderna, Inc. (Nasdaq:MRNA) announced its strategic collaboration with Generation Bio Co. (Nasdaq:GBIO) to combine Moderna’s biological and technical expertise with...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. December 13, 2022

Entrada Therapeutics’ Global Collaboration with Vertex Pharmaceuticals Incorporated

By Martina Bellini

Goodwin Procter advised Entrada Therapeutics, Inc. on the deal. Entrada Therapeutics, Inc. (Nasdaq: TRDA) announced its global collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to focus...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. November 23, 2022

Merck’s $1.35 Billion Acquisition of Imago BioSciences, Inc.

By Martina Bellini

Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck. Merck (NYSE: MRK) and Imago BioSciences, Inc....

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. October 6, 2021

Qualcomm and SSW Partners’ Acquisition of Veoneer

By Laura Testa

Paul, Weiss, Rifkind, Wharton & Garrison advised Qualcomm. Davis Polk & Wardwell advised SSW Partners. Skadden, Arps, Slate, Meagher & Flom and Roschier advised Veoneer on...

This content is for Standard 1 Year members only.
Login Join Now

North America Legal Chronicle. October 4, 2021

Merck’s $11.5 Billion Acquisition of Acceleron Pharma

By Laura Testa

Covington & Burling and Gibson, Dunn & Crutcher advised Merck, while Ropes & Gray advised Acceleron. Skadden, Arps, Slate, Meagher & Flom represented Centerview Partners LLC...

This content is for Standard 1 Year members only.
Login Join Now

North America. North America Legal Chronicle. July 30, 2021

Absci Corporation’s $200 Million Initial Public Offering

By Martina Bellini

Goodwin Procter advised Absci, while Latham & Watkins represented the underwriters in the offering. Absci Corporation (Absci), the synthetic biology company unlocking the potential of proteins...

This content is for Standard 1 Year members only.
Login Join Now

North America. North America Legal Chronicle. June 30, 2021

Doximity’s $605.8 Million IPO

By Martina Bellini

Goodwin Procter LLP advised Doximity on the deal. Doximity (NYSE: DOCS) announced its initial public offering of 23,300,000 shares of its Class A common stock at a...

This content is for Standard 1 Year members only.
Login Join Now

North America. North America Legal Chronicle. May 26, 2021

COMPASS Pathways’ $144 Million Shares Offering

By Martina Bellini

Goodwin Procter LLP advised COMPASS Pathways plc on the deal. COMPASS Pathways plc (Nasdaq: CMPS) announced its public follow-on offering of 4,000,000 American Depositary Shares (“ADSs”) representing...

This content is for Standard 1 Year members only.
Login Join Now

Igneo Infrastructure Partners’ Acquisition of Majority Equity Interest in Soltage

Datasea’s $2 Million Common Stock Offering

Blue Bird’s $52.5 Million Common Stock Secondary Offering

Metalcred XI’s US$6 Million Debt Issuance

Fabula Content’s Series A Investment Round

Ruta 3 Automotores’ AR$300 Million Notes Offering

Corti’s Series B Funding Round

ICR’s Acquisition of Consilium Strategic Communications

Allstaff’s Transition to an Employee Ownership Trust

Post For Investment’s Acquisition of Roaderz Technologies

YANMU Logistics Park’s Financing Agreement with CIB

Beltone’s Share Purchase Agreement with Cash

Panaxia Labs Israel’s Share Swap Agreement with the Barak Group

Menora Mivtachim’s Public Offering

International Schools Partnership’s Acquisition of The English College

Bayfront Infrastructure’s US$410 Million Asset-Backed Securities

Pioneer Reward Limited’s US$3 Billion Medium Term Note Programme

State Power Investment’s Green Power Purchase Agreement with BASF

stevensdrake Welcomes Nusrat Qureishi as Head of Corporate and Commercial Law, Associate Director

Polsinelli Continues Corporate Growth Momentum With Two New Shareholders in St. Louis

King & Spalding Obtains Foreign Law License from the Saudi Arabia’s Ministry of Justice

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant

stevensdrake Welcomes Nusrat Qureishi as Head of Corporate and Commercial Law, Associate Director

Polsinelli Continues Corporate Growth Momentum With Two New Shareholders in St. Louis

Leading Corporate and M&A Partner Joins Squire Patton Boggs in Dubai

James Matarese

Evelo Biosciences’ $25.5 Million Private Placement

Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding

Mercy BioAnalytics’ $41 Million Series A Financing

Avadel Pharmaceuticals’ $75 Million Royalty Financing

Moderna’s Collaboration with Generation Bio

Entrada Therapeutics’ Global Collaboration with Vertex Pharmaceuticals Incorporated

Merck’s $1.35 Billion Acquisition of Imago BioSciences, Inc.

Qualcomm and SSW Partners’ Acquisition of Veoneer

Merck’s $11.5 Billion Acquisition of Acceleron Pharma

Absci Corporation’s $200 Million Initial Public Offering

Doximity’s $605.8 Million IPO

COMPASS Pathways’ $144 Million Shares Offering